The Health-System Pharmacist Role in Optimizing Outcomes for Patients Who Need DOAC Reversal Agents

Pharmacy Times Health Systems Edition, March 2019, Volume 8, Issue 2

FACULTY

James S. Kalus, PharmD, FASHP Director of Pharmacy Henry Ford Health System Detroit, Michigan

EDUCATIONAL OBJECTIVES

At the completion of this activity the participant will be able to:

  • Analyze the unaddressed gaps of reversal agents for direct oral anticoagulants (DOACs) and the risk of bleeding complications
  • Identify patients who are at high risk for major bleeding secondary to DOAC use
  • Examine current and emerging DOAC reversal agents and their safety and efficacy
  • Explore the role of the health-system pharmacist in ensuring optimal management of the patient with DOAC-associated bleeding and implementing standards of practice for reversal agents using clinical vignettes

TARGET AUDIENCE: Health-system pharmacists

ACTIVITY TYPE: Application

RELEASE DATE: March 15, 2019

EXPIRATION DATE: March 15, 2020

ESTIMATED TIME TO COMPLETE ACTIVITY: 2 hours

FEE: This lesson is offered for free at www.pharmacytimes.org.